169949-48-8Relevant articles and documents
USP30 INHIBITORS
-
Page/Page column 24, (2018/12/13)
The application relates to phenyl- or naphthylsulfonamide derivatives of the structural formula (I). The compounds are described as inhibitors of USP30 (ubiquitin specific peptidase 30) useful for the treatment of conditions involving mitochondrial defects including neurodegenerative diseases such as Alzheimer's and Parkinson's or a neoplastic disease such as leukemia.
Design of benzamidine-type inhibitors of factor Xa
Gabriel, Bernhard,Stubbs, Milton T.,Bergner, Andreas,Hauptmann, J?rg,Bode, Wolfram,Stürzebecher, J?rg,Moroder, Luis
, p. 4240 - 4250 (2007/10/03)
A series of derivatives of rac-benzenesulfonyl-glycyl-phenylalanine or its ethyl ester with a combination of thioamido/amidino or amidino/amidino substituents in the benzene rings was synthesized as potential inhibitors of factor Xa (fXa). Among these, th